InvestorsHub Logo
icon url

Rameses

08/15/22 9:45 AM

#144598 RE: Edward #144597

Iroquois ended up with 2 Directors out of 7.

5 Directors are PharmaCyte's Nominated Directors
2 Directors are Iroquois' Nominated Directors

5 > 2

I would say PharmaCyte won.
icon url

Rameses

08/15/22 6:06 PM

#144618 RE: Edward #144597

PharmaCyte definitely came out ahead in this agreement. There is a standstill period that is a minimum of 2 years and could be longer.

[[Pursuant to the terms of the Cooperation Agreement, Iroquois also agreed to certain customary standstill provisions lasting from the date of the Cooperation Agreement through the date that is the later of (i) September 30, 2024 or (ii) the date on which neither of the Iroquois Appointees (nor their respective designated replacements) continues to serve on the Board (the date of the Cooperation Agreement through such later date, the “Standstill Period”).]]

Also, notice the language, "the date on which neither of the Iroquois Appointees..." Neither of the 2 and only 2.